Ascare Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 07-07-2024
- Paid Up Capital ₹ 1.50 M
as on 07-07-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.00 M
as on 07-07-2024
- Revenue -41.15%
(FY 2022)
- Profit -35.79%
(FY 2022)
- Ebitda 34.52%
(FY 2022)
- Net Worth 9.56%
(FY 2022)
- Total Assets -50.38%
(FY 2022)
About Ascare Pharma
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹9.00 M.
Rakeshkumar Patel, Ashokkumar Patel, and Tejalben Patel serve as directors at the Company.
- CIN/LLPIN
U51909GJ2017PTC099070
- Company No.
099070
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Sep 2017
- Date of AGM
02 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Ascare Pharma?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakeshkumar Patel  | Director | 13-Sep-2017 | Current |
| Ashokkumar Patel | Director | 13-Sep-2017 | Current |
| Tejalben Patel | Director | 13-Sep-2017 | Current |
Financial Performance of Ascare Pharma.
Ascare Pharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 41.15% decrease. The company also saw a substantial fall in profitability, with a 35.79% decrease in profit. The company's net worth moved up by a moderate rise of 9.56%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ascare Pharma?
In 2021, Ascare Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 25 Jan 2022 | ₹5.00 M | Open |
Others Creation Date: 18 Jul 2020 | ₹4.00 M | Open |
How Many Employees Work at Ascare Pharma?
Unlock and access historical data on people associated with Ascare Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ascare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ascare Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
